Introduction {#Sec1}
============

Heat shock proteins (HSPs) constitute a large group of chaperone proteins found in virtually all organisms. HSPs are classified into several families on the basis of their molecular size and amino acid sequence similarity. The largest family is HSPA (previously called HSP70; Kampinga et al. [@CR21]) which in humans includes 13 genes. In human cells, genes belonging to this family exhibit highly differentiated expression patterns, intracellular localization and function. Some of them are highly inducible by heat shock and other environmental and endogenous stimuli but most are expressed under physiological conditions and their transcription is only moderately affected by stress. Also, at physiological temperature the expression levels of various *HSPAs* may be significantly divergent, from barely detectable, to reaching up to several percent of cellular protein content.

The knowledge on the expression pattern of *HSPA* genes in human cells comes from studies performed using cells grown in vitro, from studies of various pathological tissues, or are inferred from animal studies. Although important knowledge has been gathered on the differential expression of *HSPA* genes in various pathologies, notably in cancer, much less is known about their expression pattern in normal human tissues in vivo. This issue seems to be especially important in the case of two groups of *HSPA* genes. The first one consists of inducible members of *HSPA* family, which are believed to be expressed at a very low level (if any) in normal tissues under physiological conditions. The second one groups genes, whose expression was originally ascribed exclusively to specific non-somatic cell types. In the present paper, we performed an immunohistochemical study using tissue microarrays (TMA) containing a broad panel of human normal tissues (Tissue Array Network, Rockville, MD, USA), in search for possible human cell-type-specific expression of HSPA2 and HSPA1 proteins.

The *HSPA2* gene was originally characterized (Bonnycastle et al. [@CR4]) as the human counterpart of rodent genes which are specifically and highly expressed in the testis (rat *Hst70* gene, Krawczyk et al. [@CR24], [@CR25]; Widlak et al. [@CR50]; Scieglinska et al. [@CR39], [@CR40], mouse *Hsp70*-*2* gene, Zakeri et al. [@CR54]; Allen et al. [@CR1]). In human testicular cells, the highest levels of the HSPA2 protein were detected in spermatocytes, spermatids and in the tail of mature spermatozoa (Son et al. [@CR43]; Huszar et al. [@CR17]). It has been suggested that HSPA2 is involved in the late stages of spermatid development (Huszar et al. [@CR17]). Aberrant expression of HSPA2 in testes has been connected with male infertility (Yesilli et al. [@CR53]; Cedenho et al. [@CR7]).

Recently, HSPA2 has attracted increased interest due to its possible involvement in carcinogenesis of non-testicular tissues. In relevant papers, Rohde et al. ([@CR35]) reported that HSPA2 is required for cancer cell growth, Garg et al. ([@CR13]) found that HSPA2 downregulation suppressed the growth of xenografted urothelial carcinoma cells. It was shown that in cancer cells heat shock stimulates trafficking of HSPA2 protein from cytoplasm to nucleus and its accumulation in centrosomes and nucleoli (Scieglinska et al. [@CR41]). Because transcript and protein encoded by the *HSPA2* gene have been found in various tumor cell lines and primary tumors (Rohde et al. [@CR35]; Piglowski et al. [@CR33]; Scieglinska et al. [@CR41]), its involvement in tumorigenesis seems to be recognized.

However, very little is known about the expression and function of the *HSPA2* gene in normal somatic cells. Interestingly, Bonnycastle et al. ([@CR4]) detected relatively high levels of *HSPA2* transcript in numerous human tissues (with exception of the liver) but a subsequent search for HSPA2 protein essentially revealed its insignificant (if any) expression (Son et al. [@CR43]). The discrepancy between the relatively high transcript level and very low level of the corresponding protein can result either from low specificity or/and affinity of polyclonal antibodies used for HSPA2 detection, or from inefficient translation of the *HSPA2* transcript, or from the specific mechanisms enabling efficient expression of the gene only in specific cell types. HSPA2 protein could not be detected, in spite of the presence of corresponding mRNA, in HCT116 human colon cancer cell line (Scieglinska et al. [@CR41]), so it seems that post-transcriptional mechanisms may downregulate the expression of HSPA2 in other cell types as well. However, it is possible that similarly as in the testis, where HSPA2 expression is restricted only to a subpopulation of germinal cells (spermatocytes and spermatids), in somatic tissues HSPA2 can also exhibit cell-type-specific expression patterns.

Another protein which has been investigated in the present study is stress-inducible HSPA1. It is a well characterized protein and a large part of the data published on the human HSPA family deals with its major stress-inducible member. In fact, in human tissues two HSPA1 proteins are expressed, namely HSPA1A and HSPA1B, which only differ by two amino acids, and which are believed to be fully interchangeable proteins (Kampinga et al. [@CR21]). They are encoded by two closely linked, intronless and stress-inducible genes, *HSPA1A* and *HSPA1B.* Expression of the*HSPA1A* and*HSPA1B* genes cannot be distinguished at the protein level and we decided to use the same name*HSPA1* for both. However, differences in their 3′-untranslated regions allow analysis of their individual RNA expression profiles. The common view on the activity of stress-inducible *HSPA1* gene is that it is expressed in unstressed normal cells at low or undetectable levels only and their activation indicates the condition of cellular stress. The HSPA1 protein is accepted as a cytoprotective agent (for review see Calderwood and Ciocca [@CR6]; Schmitt et al. [@CR38]). Expression of HSPA1 can be highly activated by various stressful stimuli and under a broad spectrum of physiopathological conditions. Significant HSPA1 expression has been found in human cancer cells grown in vitro as well as in various primary tumors and metastases \[for review see Ciocca and Calderwood ([@CR8])\]. However, much less is known to what extent HSPA1 could be expressed in non-stressed human somatic tissues in vivo. No systematic investigation has been performed so far and a vast majority of data comes from research focused on HSPA1 protein expression in primary tumors, in which few samples of cancer adjacent tissues were assessed as a control. It has been shown that inducible HSPA1 can be constitutively expressed in selected cell types. For example, HSPA1 was found in epithelial cells of normal human endometrium and ectocervix (Mangurten et al. [@CR28]) and in keratinocytes from differentiating layers of epidermis (Trautinger et al. [@CR47]) while no or only weak expression was detected in surrounding cells. The ability to induce HSPA1 expression can be cell-type-specific as it was shown that in human esophagus heat shock downregulated the *HSPA1* gene activity (Yagui-Beltran et al. [@CR52]).

The present immunohistochemical study was meant to gather new extensive data on the possible constitutive cell-type-specific expression of the HSPA1 and the HSPA2 proteins in human somatic tissues. We screened samples of 24 normal tissues derived from up to 11 donors. We found that both HSPA2 and HSPA1 proteins are expressed in a cell-type-specific manner and that their expression patterns differ significantly. These results indirectly suggest that in normal tissues these proteins can be involved in the regulation of various, possibly non-overlapping cellular processes. Moreover, our study provides the basis for future investigations concerning cell-type-specific function of these proteins in normal human tissues.

Materials and methods {#Sec2}
=====================

Tissues {#Sec3}
-------

TMA containing human tissues were purchased from Tissue Array Network (Rockville, USA). In accordance with the manufacturer's information, all tissue samples were fixed in formalin, processed in tissue processor (no more than 24 h of fixation) and finally embedded in paraffin. The TMA \#BN961 contains 102 spots (1.5 mm diameter) of the following 24 tissue types (4 spots for each): adipose, adrenal gland, breast, bronchus, cerebellum, cerebrum, colon, diaphragm, esophagus, heart, kidney, liver, lung, lymph node, ovary, pancreas, prostate, skeletal muscle, skin, small intestine, spleen, stomach, testis and uterus. The second TMA, \#MC5002, contained 500 spots (0.6 mm diameter) of tumor and normal tissue samples, derived from different organs. In total, it contained normal samples (healthy tissues or pathologically normal tissues adjacent to the tumor) from 17 anatomical locations: bladder (5), brain (5), breast (5), colon (5), kidney (5), liver (5), lung (5), lymph node (10), ovary (5), pancreas (5), prostate (5), skin (10), stomach (5), testis (5), thyroid (5), uterus (5). Numerals in parentheses indicate number of samples (each sample derived from a different donor).

Production and purification of rabbit Anti-HSPA2 serum {#Sec4}
------------------------------------------------------

To generate anti-HSPA2 rabbit polyclonal antibody, C-terminal peptide (NH2-SKLYQGGPGGGGSSGGPT), corresponding to amino acids 611--628 in the mouse HSPA2 sequence was selected because of the highest level of divergence between HSPAs amino acid sequence (Rosario et al. [@CR36]; Scieglinska et al. [@CR41]). Human HSPA2 peptide corresponding to the selected sequence was not considered as antigenic peptide because of the presence of gycine-rich seven amino acid-long insertion (GGGGSGA) after serine 623. BLAST search indicated high similarity between the human HSPA2 C-terminal peptide and glycine-rich motifs present in other proteins. For immunization, the peptide was C-terminally conjugated with bovine thyroglobulin (Sigma-Genosys Custom Peptide Antisera Facility). The anti-HSPA2 serum was purified by antigen affinity purification as described earlier (Sambrook et al. [@CR37]; Scieglinska et al. [@CR41]). We used frozen human testes as a source of antigen. Testes samples were homogenized on ice in 3--5 volumes of buffer containing 50 mM Tris--HCl (pH 7.5), 150 mM NaCl, 0.1% Nonidet P-40, 50 mM NaF, 1 mM DTT, 1 mM PMSF, a protease inhibitor mixture (Complete™, Roche) and centrifuged at 15,000*g* for 10 min at 4°C. Supernatant was aliquoted and total protein content was determined using Protein Assay Kit (BioRad). Protein extract (1.2 mg) was separated by SDS-PAGE on 8% polyacrylamide gel and immobilized on nitrocellulose membrane. The membrane fragment containing 70 kDa proteins was excised and incubated for 4 h at RT with rabbit HSPA2-antiserum diluted in 5% milk in TBS (50 mM Tris (pH 7.0), 150 mM NaCl). After incubation with antiserum, the membrane was washed three times for 5 min in TBS buffer supplemented with Tween-20 at a final concentration of 0.025%. Next, antigen bound antibody was eluted by incubation in 200 mM glycine solution (pH 2.8) for 25 min and neutralized by addition of 1 M Tris (pH 7.5) to a final concentration of 100 mM. Aliquots of anti-HSPA2 antibody were stored at −20°C. Specificity of each stock of purified anti-HSPA2 serum was confirmed by Western blot and immunocytochemistry.

### Western blotting {#Sec5}

Protein extracts from frozen post-surgical human testes (a gift from dr R. Nowak) and from HepG2 and A549 cell lines were prepared on ice in buffer containing 50 mM Tris--HCl (pH 7.5), 150 mM NaCl, 0.1% Nonidet P-40, 50 mM NaF, 1 mM DTT, 1 mM PMSF, a protease inhibitor mixture (Complete^TM^, Roche). After centrifugation at 15,000*g* for 10 min at 4°C, supernatant was aliquoted and total protein content was determined using Protein Assay Kit (BioRad). 30 μg of protein extracts were separated by SDS-PAGE on 8% polyacrylamide gel and immobilized on a nitrocellulose membrane (Protran, Whatman, Dassel, Germany). Blots were blocked in 5% skimmed milk in TTBS (0.25 M Tris--HCl (pH 7.5), 0.1% Tween-20, 0.15 M NaCl) for 60 min and incubated overnight at 4°C with either preimmune rabbit serum (1:5,000) or anti-HSPA2 rabbit polyclonal serum (1:5,000) or purified anti-HSPA2 monospecific polyclonal antibody (1:100). Primary antibodies were detected by goat anti-rabbit horseradish peroxidase conjugated secondary antibody (Pierce) and visualized using SuperSignal1 West Pico Chemiluminescent Substrate Kits (Pierce).

0.5 μg of human recombinant HSPA2-GST fusion protein (Abnova), HSPA6 (StressGen), HSPA1 and HSPA8 (gifts from Prof. A. Żylicz) were separated by SDS-PAGE on 8% polyacrylamide gel and immobilized on nitrocellulose membrane (Whatman). Immunodetection was performed as described above, as primary antibodies purified anti-HSPA2 (1:100) or monoclonal anti-HSPA1 (1:1,000, clone SPA810; StressGen) were used.

### Immunohistochemistry {#Sec6}

TMA slides containing paraffin-embedded tissue spots were coated by manufacturer with an extra layer of paraffin to preserve antigenicity. Before deparafinization slides were baked at 60°C for 1 h in an oven on a vertical rack to melt the coated paraffin. To enhance imunohistochemical specificity before immunostaining, antigen retrieval was performed by two 5-min cycles of boiling in 0.01 M citrate buffer in a microwave oven. The endogenous peroxidase activity was blocked with 1% H~2~O~2~ in PBS and slides were incubated overnight with primary antibodies. The following primary antibodies were used: rabbit monospecific polyclonal anti-HSPA2 (described above), mouse monoclonal anti-Hsp70 SPA810 (StressGen Biotechnologies), mouse monoclonal anti-cytokeratin10 (Novocastra), mouse monoclonal anti-cytokeratin5/6 (Dako). The immunohistochemistry procedure was performed using an IMPRESS Universal kit (Vector) according to the manufacturer's guidelines; 3,3′-diaminobenzidine (Sigma-Aldrich, Inc.) was applied as a chromogen for visualization of immunoreaction, while hematoxylin was used for counterstaining. Negative controls for specificity of the HSPA2 staining were performed by either omitting the primary antibody or by peptide competition. For the latter one, the HSPA2 antibody in working concentration was preincubated for 1 h at room temperature with mass excess of the peptide antigen (1 μg) used for rabbits immunization. All steps were performed in a humid chamber at room temperature. Both controls gave similar results.

To score the immunohistochemistry, we used the semi-quantitative methodology with respect to the intensity of immunological staining. Array spots were scored relative to staining intensity observed in the positive control: testes for HSPA2 and prostate for HSPA1. Bright/dark intensity visible at low magnification (40×), and equal to that observed in the positive control---strong staining. Definitively lighter than bright/dark and visible at low magnification (40×)---moderate staining. Staining that could be disclosed at 100× magnification---weak staining. Barely visible staining confirmed only at high magnification (400×) or lack of signal---no staining. All specimens were analyzed by two separate investigators.

Results {#Sec7}
=======

The expression of HSPA1 and HSPA2 proteins was examined by immunohistochemistry using two commercially available TMAs obtained from Tissue Array Network. The microarray contained multiple spots of various normal human tissues listed in the "[Material and methods](#Sec2){ref-type="sec"}" section. To determine the expression pattern of the HSPA2 protein in human somatic tissues we used rabbit monospecific polyclonal antibody (Scieglinska et al. [@CR41]). Western blot results confirmed the specificity of anti-HSPA2 antibody as no unspecific binding of the antibody to proteins extracted from human testes and cell lines was detected (Fig. [1](#Fig1){ref-type="fig"}b). This antibody also did not cross-react with other members of human HSPA family including stress-inducible HSPA1 and HSPA6 proteins or constitutively expressed HSPA8 protein (Fig. [1](#Fig1){ref-type="fig"}c). The expression of inducible HSPA1 protein was evaluated using commercially available antibody (SPA810, StressGen Biotechnologies, Malusecka et al. [@CR27]). As shown in Fig. [1](#Fig1){ref-type="fig"}c commonly used SPA-810, did not cross-react to HSPA8 and HSPA2 protein; however, its cross-reactivity to HSPA6 was observed (Fig. [1](#Fig1){ref-type="fig"}c). The HSPA6 is a strictly inducible member of the HSPA family (Noonan et al. [@CR30]) and it was shown that at 37°C the HSPA6 protein has a very short half-life (Noonan et al. [@CR31]). Because HSPA6 has never been detected in cells under normal conditions we claim that in normal human tissues only the HSPA1 protein could be detected using SPA810 antibody. Our study reveals that HSPA2 is expressed in a tissue- and cell-type-specific manner, and the expression pattern of this protein is significantly different, as compared to HSPA1. The most relevant results of the analysis are described below and summarized in Table [1](#Tab1){ref-type="table"}. Additionally, pictures of corresponding whole tissue spots stained with H&E, anti-HSPA2 and anti-HSPA1 antibodies captured at low magnification (40×) are available in Online Resource 1.Fig. 1Specificity of anti-HSPA2 antibody**.** **a** Protein extract isolated from human testes was subjected to Western blot analysis. HSPA2 was detected with rabbit preimmune serum (*left blot*) or unpurified anti-HSPA2 rabbit polyclonal serum (*right blot*). **b** Protein extracts from human cell lines and human testes were subjected to Western blot analysis. We used proteins from HepG2 and A549 cell lines which previously were identified as not-transcribing and transcribing *HSPA2* gene, respectively (Scieglinska et al. [@CR41]). For HSPA2 detection antigen affinity purified anti-HSPA2 antibody was used. **c** Purified recombinant human HSPA1, HSPA2-GST, HSPA6 and HSPA8 proteins (0.5 μg each) were analyzed by Western blot. *Left panel* specific detection of HSPA2-GST protein with purified anti-HSPA2 antibody. *Right panel* commercially available anti-HSPA1 antibody (SPA-810) cross-reacts with HSPA6 protein. **d** Immunohistochemical detection of HSPA2 protein in testes. *1* example of testis tissue spot stained with anti-HSPA2 antibody; *2* higher magnification, note strong HSPA2 staining in spermatocytes (*red asterisk*) and spermaitds (*green triangles*), no staining in spermatogonia (*white arrow*); *3* specificity of HSPA2 detection in testes (anti-HSPA2 antibody and peptide competition, for details see "[Material and methods](#Sec2){ref-type="sec"}" section); *4* testis stained with anti-HSPA1 antibody. *Bar* 100 μmTable 1HSPA2 and HSPA1 expression in human tissues---summary of resultsTissueNo cases/no spotsHSPA2Cell type/cell layerHSPA1Cell type/cell layerEST^a^ProteinEST^b,\ c^ProteinAdipose tissue1/40--2975/610--Adrenal gland1/460+Cortex---zona reticularis cells (cytoplasm---moderate)1807/391+Cortex---zona reticularis cells, zona fasiculata, zona glomerulosa (nucleus---moderate)Bladder6/90--907/1176+Epithelium---all layers (nucleus---strong)Breast6/913--750/104+Myoepithelial and epithelial cells (strong)Bronchus1/4No data+Epithelium---goblet cells (nucleus---strong), basal cells (nucleus---strong), ciliated cells (cytoplasm, moderate)No data+Epithelium---basal cells (cytoplasm, nucleus---moderate)Cardiac muscle1/466--1885/357+Endothelial cellsCerebellum1/4No data+White matter cells (nucleus, cytoplasm---strong)No data--Cerebrum6/9641+Glial cells (nucleus, cytoplasm---strong)990/224--Colon6/976+Epithelium---goblet cells (nucleus---moderate);1113/166--Smooth muscle fibers of lamina muscularis mucosae (cytoplasm, nucleus---moderate)Esophagus1/4247+Epithelium---basal layer cells (strong)3364/1731+Epithelium---all layers (nucleus, cytoplasm---moderate)Kidney6/9198+Cortex---distal tubules (moderate)972/226+Cortex---glomerulus, Bowman's capsule and renal tubules (moderate)Liver6/94--375/72--Lymph node11/140--10/10--Prostate6/921--1209/195+Epithelium---basal cells (nucleus---strong)Skeletal muscle1/427--259/55--Skin11/14147+Epidermis---keratinocytes of basal layer (nucleus---strong)346/61+Epidermis---keratinocytes of all layersSmall intestine1/4No data+Epithelium---goblet cells (nucleus---weak),\
Paneth cells; smooth muscle fibers of lamina muscularis mucosae (cytoplasm, nucleus---moderate)No data--Spleen1/492--7469/1427--Stomach5/541+Epithelium---parietal cells (spots in cytoplasm---weak)714/165--Testis6/9553+Spermatocytes and spermatids (strong)260/42--Thyroid5/50--947/315--Data on relative EST number extracted form UNIGENE database (<http://www.ncbi.nlm.nih.gov/unigene>)^a^Number of EST corresponding to *HSPA2* gene per million of transcripts in given tissue^b^Number of EST corresponding to *HSPA1A* gene per million of transcripts in given tissue^c^Number of EST corresponding to *HSPA1B* gene per million of transcripts in given tissue

Testis {#Sec8}
------

The expression pattern of HSPA2 in human testes has been already unequivocally established in earlier studies (Son et al. [@CR43]; Huszar et al. [@CR17]). Thus, immunohistochemical examination of testicular tissue (9 spots/6 cases) was used as a positive control. As expected, strong HSPA2 staining was observed in spermatocytes and spermatids, while no signal was found in spermatogonia and in somatic testicular cells (Fig. [1](#Fig1){ref-type="fig"}d). Positive signal was not observed when spots were probed with antibody recognizing HSPA1 protein (Fig. [1](#Fig1){ref-type="fig"}d, Online Resource 1). This finding indicates that, similarly as in rodents' testes, HSPA1 is not expressed in non-stressed human testicular germ and somatic cells (Izu et al. [@CR18]; Widlak et al. [@CR51]). Peptide competition reaction performed as control of specificity proved highly reliable detection of the HSPA2 protein in testes by our anti-HSPA2 antibody (Fig. [1](#Fig1){ref-type="fig"}d).

Skin and breast {#Sec9}
---------------

Examination of HSPA2 expression revealed cell type-specific HSPA2 staining in stratified squamous epithelium of skin (14 spots/11 cases). Strong HSPA2 staining was detected in cells constituting the basal layer of epidermis (Fig. [2](#Fig2){ref-type="fig"}b, Online Resource 1). Positive signal observed in keratinized outermost layer of the epidermis was identified as unspecific by peptide competition reaction (compare Fig. [2](#Fig2){ref-type="fig"}b, f). To confirm the identity of the HSPA2-positive cells we stained human skin with antibody-specific for cytokeratin 5/6, a marker of epidermal basal layer (Fig. [2](#Fig2){ref-type="fig"}d). Results of the above analysis strongly suggest that HSPA2 is expressed in the basal keratinocytes expressing cytokeratin 5/6, while it is not present in spinal and granular layer keratinocytes which express cytokeratin 10 (Fig. [2](#Fig2){ref-type="fig"}d, e). In contrast to the highly focused expression of HSPA2, the expression of HSPA1 was observed in all layers of epidermis (Fig. [2](#Fig2){ref-type="fig"}c, Online Resource 1). The above findings were confirmed in a separate experiment performed using postsurgical skin specimens (data not shown).Fig. 2Detection of HSPA2 and HSPA1 in epidermis and breast tissue. Skin sections stained with H&E (**a**), anti-HSPA2 (**b**), anti-HSPA1 (**c**), anti-cytokeratin5/6 (**d**), anti-cytokeratin10 (**e**) antibodies; negative control---result of peptide competition reaction (**f**). Breast sections stained with H&E (**g**), anti-HSPA2 (**h**) and anti-HSPA1 (**i**) antibodies. *Black triangle* points at basal layer of epidermis. *Red arrowhead* indicates unspecific signal in keratinized zona lucida of epidermis. *Bar* 100 μm

The expression of HSPA2 was also analyzed in breast tissue (9 spots/6 cases). We found that HSPA2 is not expressed in normal breast, only in one case a few scattered, weakly stained cells were found (Fig. [2](#Fig2){ref-type="fig"}h, Online Resource 1). On the contrary, strong HSPA1 staining was detected in breast glandular epithelium, both in myoepithelial and epithelial cells (Fig. [2](#Fig2){ref-type="fig"}i, Online Resource 1).

Bronchial and lung tissues {#Sec10}
--------------------------

The ciliated pseudostratified columnar epithelium lining the respiratory tract is another tissue identified as positive in terms of HSPA2 expression (Fig. [3](#Fig3){ref-type="fig"}). We analyzed bronchial (4 spots/1 case) and lung (9 spots/5 cases) tissues, respectively. Strong HSPA2 reaction was found in the cell layer closest to the basement membrane and in goblet cells, which are specialized for secretion of mucus (Fig. [3](#Fig3){ref-type="fig"}b). Moderate HSPA2 staining was also detected in ciliated cells in the region nearest to their apical surface (Fig. [3](#Fig3){ref-type="fig"}b). In contrast, moderate HSPA1-positive reaction could be detected only in some cells of pseudostratified columnar epithelium and was not observed in goblet cells (compare Fig. [3](#Fig3){ref-type="fig"}b, c). No HSPA2 and HSPA1 expression was detected in lung alveolar cells and connective tissue.Fig. 3Detection of HSPA2 and HSPA1 proteins in bronchus. Bronchus section were stained with **a** H&E, **b** anti-HSPA2 antibody, **c** anti-HSPA1 antibody. *Black asterisks* goblet cells, *black triangles* ciliated cells. *Bar* 100 μm

Gastrointestinal tract tissues {#Sec11}
------------------------------

TMAs used in this study contained sections of esophagus (1 case/4 spots), stomach (5 cases/5 spots), colon (6 cases/9 spots) and small intestine (1 case/4 spots), as well as liver (6 cases/9 spots) and pancreas (6 cases/9 spots). HSPA2 staining was observed in non-keratinizing squamous epithelium of esophagus (Fig. [4](#Fig4){ref-type="fig"}b, Online Resource 1). Similarly as for keratinizing epithelium of the skin, strong HSPA2 reaction was observed only in cells constituting stratum basale layer (Fig. [4](#Fig4){ref-type="fig"}b). HSPA2 was also detected in intestinal epithelia of the colon and small intestine. In these cases HSPA2 staining was observed in nuclei of goblet cells (Fig. [4](#Fig4){ref-type="fig"}e, g) which were also identified as HSPA2-positive in bronchial epithelium. Goblet cells stained with anti-HSPA2 antibody were localized closer to the crypts bottom (Fig. [4](#Fig4){ref-type="fig"}e, Online Resource 1). In small intestine mucosa, HSPA2 was visible in Paneth cells, which are specialized in secretion of anti-bacterial protein (Fig. [4](#Fig4){ref-type="fig"}h). Additionally, in small intestine and colon tissues, HSPA2 staining was observed in cells of smooth muscle fibers of lamina muscularis mucosae (Fig. [4](#Fig4){ref-type="fig"}e, Online Resource 1). In the stomach, a spotty HSPA2 staining was observed in epithelial parietal cells, which are specialized in secretion of gastric acid (Fig. [4](#Fig4){ref-type="fig"}i). No HSPA2 expression was detected in the pancreas and the liver (not shown).Fig. 4Detection of HSPA2 and HSPA1 in tissues of gastrointestinal tract. Esophagus cross-section stained with H&E (**a**), anti-HSPA2 (**b**) and anti-HSPA1 (**c**) antibodies; *black arrowhead* denotes basal layer of the esophageal epithelium. Colon stained with H&E (**d**), anti-HSPA2 (**e**) and anti-HSPA1 (**f**) antibodies; in **e** note HSPA2 staining in nuclei of goblet cells (*white arrows*) and in smooth muscle cells of muscularis mucose (*Mu*). Small intestine stained with anti-HSPA2 antibody; *white arrows* point at goblet cells (**g**) and *asterisk* at Paneth cells (**h**). **i** Detection of HSPA2 in stomach tissue: *black arrows* indicate parietal cells. *Bar* 100 μm. For low magnification (×40) pictures see Online Resource 1

Differences between HSPA2 and HSPA1 expression patterns were also observed in gastrointestinal tract tissues. While HSPA1 positive cells were distributed in all epithelial layers of esophageal epithelium (Fig. [4](#Fig4){ref-type="fig"}c, Online Resource 1), a HSPA2 stained cells were observed in striatum basale layer only (Fig. [4](#Fig4){ref-type="fig"}b, Online Resource 1).

No HSPA1 expression was observed in other samples of gastrointestinal tract tissues.

Urinary system and prostate {#Sec12}
---------------------------

Investigated TMAs contained samples of kidney cortex (6 cases/9 spots), bladder (5 cases/5 spots) and prostate (6 cases/9 spots) tissues, respectively. Immunohistochemical study revealed a highly significant difference between expression pattern of HSPA2 and HSPA1 in these tissues. In kidney cortex a moderate HSPA2 staining was detected in distal tubules only, while it was not observed in: other types of tubules, glomeruli and Bowman's capsule (Fig. [5](#Fig5){ref-type="fig"}b). The HSPA1 staining intensity varied between kidney cortex samples spotted on TMAs. An example of the highest intensity staining is shown on Fig. [5](#Fig5){ref-type="fig"}c (see also Online Resource 1). In this case moderate HSPA1 staining was observed in cells of glomerulus, Bowman's capsule and renal tubules. In bladder and prostate epithelia strong HSPA1 staining was detected (Fig. [5](#Fig5){ref-type="fig"}f, i, Online Resource 1) while no HSPA2 signal was observed (Fig. [5](#Fig5){ref-type="fig"}e, h, Online Resource 1). HSPA1 was found in all layers of bladder transitional epithelium (Fig. [5](#Fig5){ref-type="fig"}f). In prostatic glandular epithelium, classified as stratified columnar epithelium composed of two functionally and morphologically different cell layers, namely luminal and basal ones, HSPA1 staining was found in basal cells only (Fig. [5](#Fig5){ref-type="fig"}i).Fig. 5Expression of HSPA2 and HSPA1 in kidney, bladder and prostate. Kidney cortex stained with H&E (**a**), anti-HSPA2 (**b**) and anti-HSPA1 (**c**) antibodies; *white arrows* indicate HSPA2 reaction in renal distal tubules. Bladder tissue stained with H&E (**d**), anti-HSPA2 (**e**) and anti-HSPA1 (**f**) antibodies. *Gray triangles* indicate HSPA1 staining in urothelium. Prostate stained with H&E (**g**), anti-HSPA2 (**h**) and anti-HSPA1 (**i**) antibodies. *Bar* 100 μm. For low magnification (×40) pictures see Online Resource 1

Adrenal gland {#Sec13}
-------------

In the adrenal gland significant differences between expression pattern of HSPA2 and HSPA1 were also revealed. Moderate HSPA2 staining was restricted to the zona reticularis of the adrenal cortex, the cells which produce precursor androgens (Fig. [6](#Fig6){ref-type="fig"}b). In contrast, moderate HSPA1 signal was shown to be evenly distributed in all three cortical zones (Fig. [6](#Fig6){ref-type="fig"}c). Differences are more clearly visible at higher magnification of the zona reticularis (Fig. [6](#Fig6){ref-type="fig"}d, e). HSPA2 staining is cytoplasmic and finely granular (Fig. [6](#Fig6){ref-type="fig"}d), while HSPA1 staining is nuclear (however, not all nuclei are stained; Fig. [6](#Fig6){ref-type="fig"}e). Analysis was done on four spots (1 case) of adrenal tissue.Fig. 6Detection of HSPA1 and HSPA2 in adrenal gland. Adrenal stained with **a** H&E, **b** anti-HSPA2 and **c** anti-HSPA1 antibodies. Detection of HSPA2 (**d**) and HSPA1 (**e**) in zona reticularis. **f** Negative control---result of peptide competition reaction. *Co* adrenal cortex, *Me* adrenal medulla, *z-g* zona glomerulosa, *z-f* zona fasiculata, *z-r* zona reticularis. *Bar* 100 μm

Brain {#Sec14}
-----

TMAs used in this study contained samples described as cerebrum tissue (6 cases/9 spots) and cerebellum (1 case/4 spots). None of the analyzed samples showed expression of HSPA1, while all of them were positive when assayed with anti-HSPA2 antibody. A representative result of the immunohistochemical analysis is shown in Fig. [7](#Fig7){ref-type="fig"} (see also Online Resource 1). In cerebellum, strong HSPA2 staining was detected in white matter, while this protein was not found in gray matter or Purkinje cells (Fig. [7](#Fig7){ref-type="fig"}c). In the case of cerebrum specimens, a strong HSPA2 positive reaction was observed in glial cells (Fig. [7](#Fig7){ref-type="fig"}a). However, due to the small size of tissue spots and due to insufficient histological description supplied by the TMA manufacturer, we were not able to define the brain structure expressing HSPA2. Thus, further studies are required, to describe in more detail HSPA2 expression in brain structures.Fig. 7Detection of HSPA2 and HSPA1 in expression in **a**, **b** cerebrum and **c**, **d** cerebellum. Tissues were stained with anti-HSPA2 (**a**, **c**) and anti-HSPA1 (**b**, **d)** antibodies. *GM* gray matter, *GL* granular layer, *WM* white matter, *black triangles* point at Purkinje cells. *Bar* 100 μm. For low magnification (×40) pictures see Online Resource 1

Other tissues {#Sec15}
-------------

Investigated TMAs contained tissues which were identified as negative in terms of expressing both HSPA proteins. Such findings concerned six analyzed tissue types: lymph node (11 cases/14 spots), thyroid (5 cases/5 spots), skeletal muscle (1 case/4 spots), spleen (1 case/4 spots), diaphragm (1 case/4 spots) and adipose (1 case/4 spots) tissues. In the case of cardiac muscle tissues (1 case/4 spots), which were negative for HSPA2 expression, HSPA1 was detected in blood vessel endothelial cells (not shown). Finally we decided to exclude from the above analysis samples of endometrium and ovary tissues, mainly due to poor quality of the material provided on TMA.

Discussion {#Sec16}
==========

In the present study we determined the expression pattern of HSPA1 and HSPA2 proteins in various normal human tissues using tissue**-**microarray based immunohistochemical analysis. We selected these two proteins of the HSPA family \[nomenclature according to Kampinga et al. ([@CR21])\] due to their unique expression properties and very limited or conflicting data on their expression in normal human cells. To our knowledge such a tissue microarray-based survey of normal human tissues for HSPA1 and HSPA2 expression has not been performed so far.

Our study shows for the first time that HSPA2 is expressed in human somatic tissues. HSPA2 was detected in 11 out of 24 tissues analyzed (Table [1](#Tab1){ref-type="table"}). In the case of HSPA1 our study revealed its unequivocal presence in 9 of 24 tissues examined (Table [1](#Tab1){ref-type="table"}). The data summarized in the Table [1](#Tab1){ref-type="table"} show that in normal human tissues the expression pattern of HSPA1 is distinctively different from that of the HSPA2, and both proteins are expressed in a tissue- and cell-type-specific manner to a significant degree.

The human genome encodes more than ten members of the HSPA family, and six of them (HSPA1A, HSPA1B, HSPA1L, HSPA2, HSPA6 and HSPA8) are classified as cytosol/nuclear proteins able to translocate between cytoplasm and nucleus (Kampinga et al. [@CR21]; Brocchieri et al. [@CR5]). Due to their very high similarity HSPA1A and HSPA1B proteins are indistinguishable by a majority of detection methods and here they are collectively called HSPA1. Generally, HSPA1 are regarded as stress-inducible chaperones required for refolding of damaged and unfolded proteins generated by various stressful conditions. However, enhanced expression of HSPA1 at physiological temperature can appear in various pathological states such as myocardial infarction, trauma, sepsis, cerebral ischemia and in various cancers. The *HSPA2* gene contains no functional HSE in the promoter and its activity is not enhanced by heat shock. Previous studies performed on a mouse model had described HSPA2 as a testis-specific protein crucial for progression of spermatogenesis (Dix et al. [@CR11]; Govin et al. [@CR14]). Diminished expression of HSPA2 in human testis was linked to infertility (Huszar et al. [@CR17]). It seems, however, that the established view of *HSPA1* and *HSPA2* gene expression patterns in human tissues needs revision at present. The common view, that cytosolic stress-inducible HSPA1 protein would play primary role during stress, while cytosolic non-inducible HSPA2 protein performs testis-specific function seems to be an over simplification. Such a conclusion can be substantially supported by data analysis of transcript levels of *HSPA* family genes derived from the UNIGENE database (<http://www.ncbi.nlm.nih.gov/unigene>). This resource predicts approximate expression patterns by assessing the relative number of Expressed Sequence Tags (ESTs) per tissue. A similar gene expression resource is the BioGPS database (<http://www.biogps.gnf.org>), which collects data analyzed on transcript level, obtained through scrutiny of high-density oligonucleotide arrays (Daugaard et al. [@CR10]; Su et al. [@CR44]). The data on*HSPA1* and*HSPA2* transcription derived from UNIGENE database are presented in Table [1](#Tab1){ref-type="table"}. EST counting clearly shows that both genes can be constitutively transcribed in various normal human tissues. The most satisfying is a significant consistency between our immunohistochemical data concerning expression of the HSPA2 protein and the ESTs data. Also, in the case of *HSPA1* genes, there is a significant correlation between the presence of both *HSPA1* transcripts (Table [1](#Tab1){ref-type="table"}) and the expression of corresponding protein (this paper) in a given normal human tissue.

Most of our results concerning the HSPA1 protein are also in agreement with data obtained in several other studies, in which the expression of this protein was investigated in selected normal human tissues. Thus, the constitutive expression of HSPA1 was detected in epithelia lining the skin (Trautinger et al. [@CR47]; Jonak et al. [@CR20]), bronchus (Bonay et al. [@CR3]), bladder (Lebret et al. [@CR26]), prostate (Cornford et al. [@CR9]), breast (Torronteguy et al. [@CR46]) and in adrenal gland (Pignatelli et al. [@CR34]). In the case of kidney, it was shown that HSPA1 expression closely parallels tissue solute concentration (Beck et al. [@CR2]). This observation may explain variable levels of HSPA1 in renal tubules, Bowman capsule and glomeruli, which were detected in our study.

A controversial issue is whether HSPA1 can be expressed in various parts of the human gastrointestinal tract (esophagus, stomach, small intestine, colon) in the absence of exogenous stressful stimuli, and our results did not solve this problem. We detected this protein in normal esophageal epithelium, and its expression pattern was highly similar to that reported by Noguchi et al. ([@CR29]). However, in contrast to other reports (Hu et al. [@CR15]; Wang et al. [@CR49]), we did not find HSPA1 in the stomach or colon epithelia. These discrepancies can be explained by the observation that in gastrointestinal tissues HSPA1 expression can be influenced by various factors. For example, in stomach mucosa HSPA1 expression was found to be reduced in individuals infected with Helicobacter pylori or subjected to anti-reflux treatment (Konturek et al. [@CR23]; Wada et al. [@CR48]). It was also shown that in rat gastric mucosa HSPA1 can be induced by stress-related increase in gastric acid content (Otaka et al. [@CR32]). Importantly, it has been also found that HSPA1 can be downregulated by active inflammation of intestinal mucosa (Tao et al. [@CR45] and ref. therein). In general, the HSPA1 can be expressed at various levels depending on exogenous and endogenous factors which cannot be easily defined \[for review see Otaka et al. ([@CR32]), Sikora and Grzesiuk ([@CR42])\].

Cell-type-specific and differential constitutive expression of HSPA1 and HSPA2 proteins in a number of human tissues suggests, that these proteins can perform in vivo-specific functions. At present, the issue whether these homologous proteins perform overlapping or distinct functions is highly debatable (Daugaard et al. [@CR10]). So far, only a few studies have been carried out to compare functional properties of HSPA1 and HSPA2. Rohde et al. ([@CR35]) found that reduced expression of HSPA1 and HSPA2 affected cancer cell growth and survival in different ways. Next, a more recent study has shown, that exogenous recombinant HSPA1 and HSPA2 proteins, were found to be transported to the lysosomes of cancer cells, but only the HSPA1 was able to enhance lysosomal stability (Kirkegaard et al. [@CR22]). On the other hand, it is also possible that different functions of HSPA proteins in vivo are not due to their specific biochemical or client binding properties, but are a result of cell-type-specific regulation of their expression. For example, in rodent testes, the HSPA2 is selectively expressed in pachytene spermatocytes and round spermatids, but not in testicular somatic cells. HSPA2 was found to be a chaperone specifically required for desynapsis of synaptonemal complexes (Allen et al. [@CR1]; Dix et al. [@CR12]), assembly of the functional CDC2/cyclin B1 (Zhu et al. [@CR55]), postmeiotic reorganization of chromatin (Govin et al. [@CR14]). The *HSPA2* gene knockout resulted in an arrest of spermatocytes differentiation and division (Dix et al. [@CR11]). In contrast, HSPA1 can be expressed in interstitial somatic cells but not in meiotic cells, even under heat shock (Huang et al. [@CR16]). Thus, due to different regulation of expression, HSPA2 is required for rodent spermatogenesis while HSPA1 is not. However, it is not known whether forced expression of HSPA1 in spermatocytes can functionally replace HSPA2 in testicular cells.

In the epithelia of skin, esophagus and bronchus, both HSPA1 and HSPA2 proteins were found to be expressed. The HSPA2 was almost selectively detected in the nuclei of basal cells, whereas HSPA1 was evenly distributed in cells of all epithelial layers. Thus, such expression patterns raise the question whether there are some cell-type-specific requirements for a particular HSPA protein and whether its specific biochemical activity or such expression pattern reflects only cell-type-specific ability to activate HSPA promoters? Constitutive expression of HSPA1 in epidermis is considered as an inherent protective mechanism against UV radiation (Jonak et al. [@CR20]). It was also shown, that HSPA1 can protect esophageal mucosa in the reflux esophagitis rat model (Izumi et al. [@CR19]). Thus, HSPA1 emerges as a cytoprotective protein in skin and esophagus epithelia. The function of HSPA2 in basal cells is completely unknown, but it is tempting to speculate that this protein can be specifically involved in the proliferation and/or differentiation of epidermal keratinocytes. Such a supposition is to some extent justified by the observation that HSPA2 is highly expressed in tumors (Rohde et al. [@CR35]; Scieglinska et al. [@CR41]; Garg et al. [@CR13]) and it is required for growth of some cancer cells in vitro (Rohde et al. [@CR35]; Garg et al. [@CR13]).

Our study, which shows that human tissues may constitutively and differentially express HSPA1 and HSPA2 proteins, is merely a preliminary, but necessary step towards the determination of their function in normal non-stressed human cells. We hope that our results can provide guidelines for designing experimental models suitable to determine cell- and tissue-type-specific functional differences between HSPA2 and HSPA1 proteins. We believe that our study justifies the conclusion that each tissue, as well as particular cell types, could be viewed as unique systems with respect to the expression of *HSPA* genes. This implies that for each particular *HSPA* homolog the regulation of gene transcription and protein function should be experimentally investigated in a most relevant model system and findings pertaining to a given tissue/cell type may not necessarily be applicable to others.
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